Introduction: Low fat free mass index (FFMI) is a component of the ESPEN diagnosis criteria 23 of malnutrition, that only when accompanied with weight loss is considered to be a determinant 24 of malnutrition. Our aims were to assess the prevalence of malnutrition in patients with chronic 25 obstructive pulmonary disease (COPD) applying the ESPEN criteria, and to examine the ability 26 of different components of the criteria to predict COPD severity, length of stay (LOS), 27 hospital readmissions within 30 days and mortality. Results: The prevalence of malnutrition according to the ESPEN criteria was 21%. The 33 association between nutritional assessment, applying different components of the ESPEN 34 criteria, and COPD severity was highly significant, with the highest risk being associated with 35 low FFMI OR (95% CI) 4.77 (2.03, 11.20; p<0.001). There was a trend towards higher risk of 36 hospitalization for >7 days in subjects with low FFMI (OR 2.46 95% CI 0.92, 6.59; p=0.074) and 37 increased risk of 6 and 9 months' mortality (OR 2.72 95% CI 0.88, 8.39, P=0.082 and OR 2.72 38 95% CI 0.94, 7.87, P=0.065, respectively) in subjects diagnosed as malnourished by the ESPEN 39 criteria. 40
Conclusion: This study describes the prevalence of malnutrition in hospitalized COPD patients 41 using the ESPEN criteria from 2015. Our findings suggest that FFMI could be used 42 independently of weight loss for the diagnosis of malnutrition in COPD patients, although there 43 remain some problems associated with its measurement in the clinical setting. The aims of the present study were to assess the prevalence of malnutrition in patients with 76 chronic obstructive pulmonary disease (COPD) applying the ESPEN criteria, and to examine the 77 ability of different components of the criteria to predict severity of COPD, length of stay (LOS), 78 hospital readmissions within 30 days and mortality. 79
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Materials and Methods 80
Subjects 81
Subjects were patients with COPD admitted to the Department of Pulmonary Medicine at 82
Landspitali during one year: March 2015-March 2016 (n=236). The most common reason for 83 admission was exacerbation of COPD. Patients who were judged to be able to maintain balance 84 on a device to measure body composition and had an anticipated length of hospitalization of >3 85 days (evaluated by medical staff in the department) were invited to participate. Information on 86 height was collected from electronic medical records in Landspitali (SAGA (TM software 87 3.1.39.9)). 88
Socio-demographic data, date of admission, readmission within 30 days, LOS and mortality at 89 six and nine months, were collected from electronic medical records SAGA (TM software 90 3.1.39.9). 91
Nutritional risk screening 92
For each patient, nutritional screening was undertaken by a trained researcher on admission using 93 the following screening tools. 94
Icelandic simple screening (ISS) 95
This screening tool is recommended by the clinical guidelines for hospital nutrition at 96 Landspitali (Friðriksdóttir, 2011) and was validated against a full nutritional assessment (weight, 97 height, BMI, serum albumin, pre-albumin, lymphocyte count, triceps skinfold thickness, mid-98 arm muscle circumference, and unintentional weight loss) in COPD patients (Thorsdottir et al., 99 2001) (appendix 1). Nutritional risk is categorized as low (score 0-1), medium (score 2-3) and 100 high (score ≥ 4). A total score of ≥4 is considered 'at nutritional risk'. whether key features are absent (score 0), mild (score 1), moderate (score 2) or severe (score 3), 107 giving a total possible score of 0-6. If patients are ≥ 70 years, 1 point is added to the final score. 108
With a total score of ≥3 a patient is considered 'at nutritional risk'. 109
ESPEN criteria for the diagnoses of malnutrition 110
The two alternative ways to diagnose malnutrition proposed by the new ESPEN criteria are 111 summarized in the Fact box. These criteria may be applied after patients have been screened 112 using a validated screening tool to identify those at risk of malnutrition. The data collected on 113 nutritional status and body composition were used to separate patients into groups according to 114 the proposed cut-offs. 115
Body composition 116
A portable, multi-frequency (20kHz, 100kHz) bioelectrical impedance analysis (BIA) device 117 (InBody230 Co., Ltd. Korea) was used to measure body composition. The method, based on a 118 low electrical current sent through the body to measure the tissue impedance, has previously 119 been validated in stable COPD patients ( The measurement was carried out by a trained researcher towards the end of the hospital stay. 132
Statistical analysis 133
For statistical analyses IBM SPSS Statistics 24 was used and the level of significance was set at 134 0.05. The Kolmogorov-Smirnov test was used to test normality of data. Descriptive analyses 135 were presented as means ± SD. Linear regression analyses were used to determine the 136 association between different variables (exposure) related to nutritional assessment: malnutrition 137 according to ESPEN diagnostic criteria, nutritional risk using two validated screening tools (ISS 138 and NRS-2002), each component of the ESPEN diagnostic criteria (unintentional weight loss, 139 age related BMI below cut offs and low FFMI) and disease severity, LOS, six and nine month 140 mortality and 30-day readmission (outcomes). According to policy at Landspitali, the aim is that 141 mean LOS should not exceed 7 days, therefore this was used as the cut-off in our analyses. 142
Adjustments were made for potential confounding variables, such as gender and lung function. The study was approved by the hospital's Bioethics Committee (reference nr. 12/2015) and the 149 medical manager at Landspitali (16, LSH 28-15). Informed written consent was obtained prior to 150 inclusion in the study. If patients were at nutritional risk, appropriate nutritional support was 151 provided e.g. energy-and protein dense food and/or oral nutritional supplement (ONS) and/or 152 dietary advice. 153
Results 154
A total of 236 patients were screened for nutritional risk during the study period. Of these, 29 155 (12%) refused to participate and another 70 (30%) patients were not eligible due to a planned 156 admission of less than three days (n=19). A further forty-two (18%) patients were excluded as 157 they were not able to stand in an upright position for 60 seconds (the time it takes to measure 158 body composition using BIA) or judged by the nursing staff to be too sick to be able to 159 participate. Nine patients were not eligible for other reasons e.g. cognitive impairment. Of those 160 who did not participate in the study, 99 (34%) were defined as at nutritional risk when using the 161 screening tool proposed by Landspitali University hospital (referred to as ISS). Prevalence of 162 nutritional risk in the group defined as not being eligible due to sickness was 18 (43%). 163
One hundred and thirty-seven patients (58.5%) consented to participate. However, 16 (12%) had 164 insufficient data available (measurement of body composition) e.g. due to admission to the ICU, Table 1 . Data on FEV 1 were available for 98 (81%) of the 121 171 subjects and off those, 56 (57%) had severe or very severe disease. Fifty-nine (48%) subjects 172 were classified by BMI as overweight or obese and 36 (30%) had low FFMI. 173
Prevalence of malnutrition 174
Nutritional screening using the ISS identified 44 (36%) patients as being at nutritional risk 175 (Table 2 ). The more widely used screening tool, NRS-2002, identified more patients at 176 nutritional risk than the ISS (n=67 (55%)). Table 2 
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Eight subjects who were found to have a low FFMI were not considered to be at nutritional risk 189 by screening. These subjects did not report weight loss in the past months and had a significantly 190 higher BMI than subjects with low FFMI defined at nutritional risk (23.5±2.6 vs. 17.9±2.0, 191 p<0.001) (supplemental table 4). 192
Outcomes 193
COPD severity 194
The association between nutritional status (defined by two different screening tools and each 195 alternative of the ESPEN criteria) and severity of COPD was highly significant, with low FFMI 196 being the variable associated with the highest risk of being at a severe or very severe stage of the 197 disease (OR 4.77 95% CI 2.03, 11.20; p<0.001) (Table 3 ). Unintentional weight loss was not 198 found to be associated with severity of COPD in our study. 199
Length of stay and readmissions 200
Higher risk of prolonged hospitalization (>7 days) was seen in subjects with low FFMI (OR 2.46 201 95% CI 0.92, 6.59; p=0.074), although the results were not statistically significant (Table 3) Being defined as at nutritional risk by the Icelandic screening sheet (ISS) was found to predict 206 mortality within 6 and 9 months from admission to the hospital (OR 3.48 95% CI 1.12, 10.37, 207 P=0.025 and OR 2.88 95% CI 1.06, 7.82, P=0.039, respectively). Unintentional weight loss also 208 independently predicted mortality 6 months after hospitalization (OR 3.88 95% CI 1.14, 13.26, 209 P=0.030). However, these associations did not remain statistically significant after adjusting for method used in this study is that it depends on the ability to stand for 60 seconds. In our study, 262 42 patients (18% of the total number of patients recruited to the hospital in the study period) 263 were excluded from participation as they were not stable enough to stand on the device. A 264 different device would therefore be required if measurements of FFMI were to be used in routine 265 clinical practice. 266
The two screening tools used in the present study were developed with quite similiar aims in 267 mind. The Icelandic tool was validated in COPD patients with the aim of identifying patients that 268 require further nutritional assessment and treatment, and the NRS-2002 was designed to identify 269 hospitalized patients likely to benefit from nutritional support not only to find those who are 270 likely to be at nutritional risk. However, there are some differences between the two tools which 271 may explain the large difference in the proportion of patients found to be at nutritional risk in 272 this study. For example, the NRS-2002 adds 1 point to the score for having COPD, therefore all 273 of our subjects received this point. Another difference is that the question; "Has the patient been 274 hospitalised for 5 days or more during previous 2 months?" is included in the ISS but not in patients. By using ISS that criteria alone gave him 4 points, which is the cut-off for being at 280 nutritional risk, and he was diagnosed as malnourished by ESPEN (Fact box, alternative 1). 281
However, by using NRS-2002 he only was allocated only 1 point for the low BMI and 1 point 282 for COPD, giving him a total score of 2 points (≥3 is considered at nutritional risk). Although 283 many tools have been developed and implemented in different patient groups, there is no 284 consensus on which tool is the most optimal. Recent meta-analysis concluded that it´s more 285 important to do the screening for nutritional risk than the screening tool itself (van Bokhorst-de 286 van der Schueren, Guaitoli, Jansma, & de Vet, 2014). 287
One of the strengths of our study is that the study population is well defined i.e. hospitalised 288 patients with COPD. However, a relatively small sample size is a limiting factor. Although, 289 statistically significant associations with being 'at nutritional risk' or being malnourished were 290 found for only a few of the outcomes assessed in our study, we cannot rule out associations 291 previously seen in other studies. In our study, unintentional weight loss was the only component 292 of the ESPEN criteria significantly associated with increased risk of mortality, although the 293 association did not remain significant after adjustment. Unintentional weight loss has previously 294 been associated with higher mortality in patients with COPD (Prescott et al., 2002) . 295
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